Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Biogen Inc. (BIIB) had Pre-Tax Income of $464.80M for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
$2.29B |
|
$393.40M |
|
$542.20M |
|
$1.75B |
|
$1.73B |
|
$558.50M |
|
$-93.70M |
|
|
Pre-Tax Income |
$464.80M |
$464.80M |
|
$393.40M |
|
$393.40M |
|
$393.40M |
|
$393.40M |
|
$558.50M |
|
$750.10M |
|
145.20M |
|
145.90M |
|
$2.71 |
|
$2.70 |
|
| Balance Sheet Financials | |
$6.76B |
|
$3.28B |
|
$19.81B |
|
$26.57B |
|
$3.22B |
|
$6.29B |
|
$8.13B |
|
$11.35B |
|
$15.21B |
|
$700.90M |
|
$15.21B |
|
145.60M |
|
| Cash Flow Statement Financials | |
$553.20M |
|
$-66.00M |
|
$-439.60M |
|
$1.05B |
|
$1.07B |
|
$24.50M |
|
$72.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.10 |
|
-- |
|
-- |
|
0.29 |
|
0.43 |
|
76.33% |
|
24.38% |
|
24.38% |
|
-- |
|
20.29% |
|
17.18% |
|
$507.30M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.22 |
|
1.15 |
|
78.57 |
|
2.59% |
|
56.13% |
|
1.48% |
|
1.83% |
|
$104.48 |
|
$3.48 |
|
$3.79 |
|